International Immunocompromised Host Society's 19th International Symposium on Infections in the Immunocompromised Host
国际免疫低下宿主协会第十九届国际免疫低下宿主感染研讨会
基本信息
- 批准号:9260163
- 负责人:
- 金额:$ 0.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-11-09 至 2017-11-08
- 项目状态:已结题
- 来源:
- 关键词:Antifungal TherapyAntiviral AgentsAreaBiological ProductsChileCollaborationsCountryDiagnosticDrug IndustryEducational workshopEnvironmentFinancial SupportGoalsHepatitisImmunocompromised HostIndividualInfectionInternationalMethodsParticipantResearchResearch PersonnelScientistSenior ScientistSocietiesTravelUnited States National Institutes of HealthUpdateWomanZika Viruscostexperiencelecturesmeetingsnovelplanetary Atmosphereposterssymposiumtoolvaccine development
项目摘要
PROJECT ABSTRACT
The 19th International Symposium on Infections in the Immunocompromised Host will be held in Santiago,
Chile at the Hotel Sheraton San Cristóbal from November 13-15, 2016. The International Immunocompromised
Host Society (ICHS) has successfully organized these Symposia for over 35 years. The ICHS Symposium is
attended by close to 400 international delegates from over 40 countries with a goal of conveying the latest
advances, treatments, and topics relevant to the immunocompromised host to a global audience. These year's
topics include: antifungal therapy, new hepatitis antiviral treatments, advances in diagnostic tools, the impact of
Zika virus on immunocompromised individuals, development of vaccines, update on current
immunosuppresors, and biological agents. Past support from the NIH for this conference has gone towards
supporting the cost of travel for new investigators, trainees, women, and underrepresented individuals to
attend. This conference promotes interactions between investigators from all over the world as well as young
investigators with experienced investigators and research scientists with clinicians.
项目摘要
第19届免疫功能低下宿主感染国际研讨会将在圣地亚哥举行,
智利于2016年11月13日至15日在圣克里斯托瓦尔喜来登酒店。国际免疫缺陷
主办协会(ICHS)已经成功地组织了这些研讨会超过35年。ICHS研讨会是
来自40多个国家的近400名国际代表参加了会议,
进展,治疗和主题相关的免疫功能低下的主机向全球观众。今年的
主题包括:抗真菌治疗,新的肝炎抗病毒治疗,诊断工具的进展,
寨卡病毒对免疫功能低下个体的影响,疫苗的开发,当前最新情况
免疫抑制剂和生物制剂。NIH过去对这次会议的支持已经转向
支助新调查员、受训人员、妇女和任职人数不足的个人前往
参加这个论坛这次会议促进了来自世界各地的研究人员以及年轻人之间的互动,
研究者与经验丰富的研究者,研究科学家与临床医生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert William Finberg其他文献
Robert William Finberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert William Finberg', 18)}}的其他基金
18th International Symposium on Infections in the Immunocompromised Host
第18届免疫低下宿主感染国际研讨会
- 批准号:
8720337 - 财政年份:2014
- 资助金额:
$ 0.6万 - 项目类别:
17th International Symposium on Infections in the Immunocompromised Host
第十七届免疫低下宿主感染国际研讨会
- 批准号:
8330069 - 财政年份:2012
- 资助金额:
$ 0.6万 - 项目类别:
16th Symposium on Infections in the Immunocompromised Host
第16届免疫低下宿主感染研讨会
- 批准号:
7994945 - 财政年份:2010
- 资助金额:
$ 0.6万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 0.6万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 0.6万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 0.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 0.6万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 0.6万 - 项目类别:














{{item.name}}会员




